For-Robin, Inc. logo

For-Robin, Inc.

For-Robin, Inc, founded in 2012 is an antibody immunotherapy company whose primary mission is developing treatments for breast and lung cancer patients. For-Robin's proprietary technology (monoclonal antibody, JAA-F11 and humanized variants, hJAA-F11) targets all breast and lung cancer cell subtypes including triple negative breast cancer where no targeted therapy currently exists. For-Robin is developing hJAA-F11 for adjunct therapy of breast and lung cancer either directly or as antibody-drug conjugates.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://for-robin.com
Founded2012
Disease Focus
Development Stage
STOCK CODENon Listed
Address
97 Troyview Lane,NY, 14221
Williamsville
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/for-robin-therapeutics-llc” connections=”true” suffix=””]